{"id":62467,"title":"Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study.","abstract":"","date":"2014-04-11","categories":"Hemic and Lymphatic Diseases","split":"test","url":"http://www.ncbi.nlm.nih.gov/pubmed/24569263","annotations":[{"name":"Imatinib","weight":0.899718,"wikipedia_article":"http://en.wikipedia.org/wiki/Imatinib"},{"name":"Chronic myelogenous leukemia","weight":0.845879,"wikipedia_article":"http://en.wikipedia.org/wiki/Chronic_myelogenous_leukemia"},{"name":"Leukemia","weight":0.816944,"wikipedia_article":"http://en.wikipedia.org/wiki/Leukemia"},{"name":"Clinical trial","weight":0.579775,"wikipedia_article":"http://en.wikipedia.org/wiki/Clinical_trial"},{"name":"Myeloid","weight":0.459079,"wikipedia_article":"http://en.wikipedia.org/wiki/Myeloid"},{"name":"Chronic (medicine)","weight":0.298818,"wikipedia_article":"http://en.wikipedia.org/wiki/Chronic_(medicine)"},{"name":"Dasatinib","weight":0.260458,"wikipedia_article":"http://en.wikipedia.org/wiki/Dasatinib"},{"name":"Phase (waves)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Phase_(waves)"}]}
